Published in
Springer, Investigational New Drugs, 3(33), p. 720-728, 2015
DOI: 10.1007/s10637-015-0212-z
Links
Tools
Biomarker-driven phase 2 study of MK-2206 and selumetinib (AZD6244, ARRY-142886) in patients with colorectal cancer
Journal article published in 2015 by
Khanh Do,
Giovanna Speranza,
Rachel Bishop,
Sonny Khin,
Larry Rubinstein,
Robert J. Kinders,
Manuel Datiles,
Michelle Eugeni,
Michael H. Lam,
L. Austin Doyle,
James H. Doroshow,
Shivaani Kummar
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 